Biochemical Reagent
-
BA6353 EGFR-IN-70Summary: EGFR-IN-70 is a potent inhibitor. -
BA6354 GW2974Summary: GW2974 is a potent dual inhibitor.
-
BA6356 PKI-166Summary: PKI-166 is a highly potent and selective, orally bioactive inhibitor.
-
BA6357 TheliatinibSummary: Theliatinib (Xiliertinib) is a potent, ATP-competitive, orally active and highly selective inhibitor.
-
BA6359 DBPR112Summary: DBPR112 is an orally effective fluoropyrimidine-based inhibitor.
-
BA6360 SelatinibSummary: Selatinib is a reversible and orally active dual and inhibitor.
-
BA6361 PD-089828Summary: PD-089828 is an ATP-competitive inhibitor and a non-competitive inhibitor of tyrosine kinases.
-
BA6362 IzalontamabSummary: Izalontamab (SI-B001) is a bispecific anti-monoclonal antibody with high selectivity for EGFR/HER3 heterodimers.
-
BA6363 RTC-5Summary: RTC-5 (TRC-382) is an optimized phenothiazine with anticancer potency.
-
BA6364 DuligotuzumabSummary: Duligotuzumab is a humanized IgG-κ monoclonal antibody.